March 9, 2018 Comments Off on New patent for Gilead Sciences drug STRIBILD Posted in: Patent Added Annual Drug Patent Expirations for STRIBILD Stribild is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from five suppliers. There are sixteen…
The post New patent for Gilead Sciences drug STRIBILD appeared firs…
Like this:
Like Loading...
March 9, 2018 Comments Off on New patent for Allergan drug COMBIGAN Posted in: Patent Added Annual Drug Patent Expirations for COMBIGAN Combigan is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. There are nine patents protecting…
The post New patent for Allergan drug COMBIGAN appeared first o…
Like this:
Like Loading...
March 9, 2018 Comments Off on New tentative approval for Watson Labs drug dienogest; estradiol valerate Posted in: Tentative Approval Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. This ingredient…
The post New tentative approval for Watson Labs dr…
Like this:
Like Loading...
March 9, 2018 Comments Off on Suspension dosed drug patent expirations by year Posted in: Infographic This chart shows the patent expirations for suspension dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
The post Suspension dosed drug patent expirations by year appeared first on Dr…
Like this:
Like Loading...
March 8, 2018 Comments Off on New patent for Astrazeneca Ab drug BYDUREON BCISE Posted in: Patent Added Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are sixteen…
The post New patent for Astrazeneca Ab drug BYDUREON BCISE app…
Like this:
Like Loading...
March 8, 2018 Comments Off on New patent for Astrazeneca Ab drug BYDUREON PEN Posted in: Patent Added Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are thirty-five…
The post New patent for Astrazeneca Ab drug BYDUREON PEN appea…
Like this:
Like Loading...
March 8, 2018 Comments Off on New patent for Astrazeneca Ab drug BYDUREON Posted in: Patent Added Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty-six patents…
The post New patent for Astrazeneca Ab drug BYDUREON appeared …
Like this:
Like Loading...
March 8, 2018 Comments Off on New patent expiration for AMGEN drug SENSIPAR Posted in: Uncategorized
Annual Drug Patent Expirations for SENSIPAR Sensipar is a drug marketed by Amgen and is included in one NDA. It is available from six suppliers. There are three patents protecting…
The post New patent expiration for AMGEN drug SENSIPAR appeared f…
Like this:
Like Loading...
March 8, 2018 Comments Off on New tentative approval for Watson Labs drug dienogest; estradiol valerate Posted in: Tentative Approval Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. This ingredient…
The post New tentative approval for Watson Labs dr…
Like this:
Like Loading...
March 8, 2018 Comments Off on Which pharmaceutical companies have the most drug patents in Brazil? Posted in: Infographic This chart shows the pharmaceutical companies with the most patents in Brazil. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug…
Like this:
Like Loading...